SPG302 was well tolerated in a trial, with preliminary data supporting the idea the therapy might slow ALS progression.
The Packard Center and ALS United will fund a preclinical study investigating how abnormal TDP-43 protein contributes to ALS.
After my husband, Todd, was diagnosed with ALS, I was shattered and desperate to connect with others who might understand the pain I was feeling.
Target ALS has released a short film about founder Dan Doctoroff’s mission to transform ALS research and bring hope to patients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback